Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Veri MedTech Holdings Inc (ID) VRHI

Veri Medtech Holdings Inc., through its subsidiaries, provides health and wellness services and products through its healthcare technology platform. Its online therapy platforms bridge the gap between mental health professionals and clients seeking support. It offers its services under Veriheal and DosePop brand names. Veri Medtech Holdings Inc. was founded in 2017 and is based in McLean, Virginia.


OTCID:VRHI - Post by User

User Avatar Image
(18)
•••
  • AveragePennyX
Post by AveragePennyon Aug 22, 2025 8:58am
19 Views
Post# 36688523

Open Market Transactions (CEO & Director) - VRHI

Open Market Transactions (CEO & Director) - VRHI

VERI MEDTECH (VRHI) Announces CEO & Director Purchase: 7,953 Additional Shares of VRHI Stock in Open Market Transactions

NEW YORK, August 22, 2025 - OTC Markets -- Veri Medtech Holdings, Inc. (Stock Ticker Symbol: “VRHI”) ("Veri Medtech"), healthcare technology platform, announced today that via open market transactions: (1) Sam Adetunji, CEO, completed the purchase of an additional 6,000 shares of VRHI stock at an average price per share of $0.98; and (2) Danny Wilson, Director, completed the purchase of an additional 1,953 shares of VRHI stock at an average price per share of $0.9387 per share, for a combined total of: 7,953 shares.  With these purchases, Mr. Adetunji beneficially owns 7,643,385 shares and Mr. Wilson beneficially owns: 491,876 shares of VRHI stock. 

Q2 Key Accomplishments:

  1. $2.86 Million in Revenue
  2. Initiated Audit Process with PCAOB Auditor (in preparation for uplisting)
  3. Relaunched www.VeriMedTech.com
  4. Engaged in Discussions for Accretive Opportunities in Mergers/Acquisitions (Healthcare Technology Companies)

https://www.otcmarkets.com/stock/VRHI/news/Open-Market-Transactions-CEO--Director---VRHI?id=490128
<< Previous
Bullboard Posts
Next >>